Susan Dana Jones

Insider Reports History

Entity
Individual
Location
C/O Tourmaline Bio, Inc., 27 West 24 Th Street, Suite 702, New York, NY
Signature
/s/ Brad Middlekauff, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Susan Dana Jones:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Tourmaline Bio, Inc. Chief Technology Officer Common Stock 22.9K $390K $16.99 Oct 19, 2023 Direct
Tourmaline Bio, Inc. Chief Technology Officer Employee Stock Option (Right to Buy) 46.8K Oct 23, 2023 Direct

Insider Reports Filed by Susan Dana Jones

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TALS Tourmaline Bio, Inc. Oct 19, 2023 3 $0 4 Oct 23, 2023 Chief Technology Officer
TALS Tourmaline Bio, Inc. Oct 19, 2023 0 $0 3 Oct 23, 2023 Chief Technology Officer